J. Exp. Med., Volume 188, Number 5, September 7, 1998 845-854

Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Secreting Merozoite Surface Protein 1 (MSP1) Induces Protection against Rodent Malaria Parasite Infection Depending on MSP1-stimulated Interferon  and Parasite-specific Antibodies

By Sohkichi Matsumoto,^* Hideharu Yukitake,^* Hiroji Kanbara, and Takeshi Yamada^*

From the ^* School of Dentistry, Nagasaki University, Nagasaki 852-8588, Japan; and the  Department of Protozoology, Institute of Tropical Medicine, Nagasaki 852-8588, Japan

The merozoite surface protein 1 (MSP1) has emerged as a leading malaria vaccine candidate at the erythrocytic stage. Recombinant bacillus Calmette-Guérin (rBCG), which expressed a COOH-terminal 15-kD fragment of MSP1 of Plasmodium yoelii (MSP1-15) as a fusion protein with a secretory protein of Mycobacterium kansasii, was constructed. Immunization of mice with this rBCG induced a higher degree of protection against blood-stage parasite infection than with recombinant MSP1-15 in the RIBI adjuvant (RIBI ImmunoChem Research, Inc., Hamilton, MT) or incomplete Freund's adjuvant systems. We studied the mechanism of protection induced by MSP1-15, and found that interferon (IFN)- had a major role in protection in all adjuvant systems we examined. Mice that produced low amounts of MSP1-15 stimulated IFN- and could not control parasite infection. The antibody against MSP1-15 did not play a major role in protection in this system. After parasite infection, immunoglobulin G2a antibodies, which had been produced by IFN- stimulation, were induced and subsequently played an important role in eradicating parasites. Thus, both cellular and humoral immune responses were essential for protection from malaria disease. These data revealed that BCG is a powerful adjuvant to induce such a protective immune response against malaria parasites.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hisaeda, H., Tetsutani, K., Imai, T., Moriya, C., Tu, L., Hamano, S., Duan, X., Chou, B., Ishida, H., Aramaki, A., Shen, J., Ishii, K. J., Coban, C., Akira, S., Takeda, K., Yasutomo, K., Torii, M., Himeno, K. (2008). Malaria Parasites Require TLR9 Signaling for Immune Evasion by Activating Regulatory T Cells. J. Immunol. 180: 2496-2503 [Abstract] [Full Text]  
• Petritus, P. M., Burns, J. M. Jr. (2008). Suppression of Lethal Plasmodium yoelii Malaria following Protective Immunization Requires Antibody-, IL-4-, and IFN-{gamma}-Dependent Responses Induced by Vaccination and/or Challenge Infection. J. Immunol. 180: 444-453 [Abstract] [Full Text]  
• Dietrich, J., Billeskov, R., Doherty, T. M., Andersen, P. (2007). Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection. J. Immunol. 178: 3721-3730 [Abstract] [Full Text]  
• Cayabyab, M. J., Hovav, A.-H., Hsu, T., Krivulka, G. R., Lifton, M. A., Gorgone, D. A., Fennelly, G. J., Haynes, B. F., Jacobs, W. R. Jr., Letvin, N. L. (2006). Generation of CD8+ T-Cell Responses by a Recombinant Nonpathogenic Mycobacterium smegmatis Vaccine Vector Expressing Human Immunodeficiency Virus Type 1 Env. J. Virol. 80: 1645-1652 [Abstract] [Full Text]  
• Page, K. R., Jedlicka, A. E., Fakheri, B., Noland, G. S., Kesavan, A. K., Scott, A. L., Kumar, N., Manabe, Y. C. (2005). Mycobacterium-Induced Potentiation of Type 1 Immune Responses and Protection against Malaria Are Host Specific. Infect. Immun. 73: 8369-8380 [Abstract] [Full Text]  
• Hu, P. Q., Tuma-Warrino, R. J., Bryan, M. A., Mitchell, K. G., Higgins, D. E., Watkins, S. C., Salter, R. D. (2004). Escherichia coli Expressing Recombinant Antigen and Listeriolysin O Stimulate Class I-Restricted CD8+ T Cells following Uptake by Human APC. J. Immunol. 172: 1595-1601 [Abstract] [Full Text]  
• Kawabata, Y., Udono, H., Honma, K., Ueda, M., Mukae, H., Kadota, J.-i., Kohno, S., Yui, K. (2002). Merozoite Surface Protein 1-Specific Immune Response Is Protective against Exoerythrocytic Forms of Plasmodium yoelii. Infect. Immun. 70: 6075-6082 [Abstract] [Full Text]  
• Grode, L., Kursar, M., Fensterle, J., Kaufmann, S. H. E., Hess, J. (2002). Cell-Mediated Immunity Induced by Recombinant Mycobacterium bovis Bacille Calmette-Guerin Strains Against an Intracellular Bacterial Pathogen: Importance of Antigen Secretion or Membrane-Targeted Antigen Display as Lipoprotein for Vaccine Efficacy. J. Immunol. 168: 1869-1876 [Abstract] [Full Text]  
• Mederle, I., Bourguin, I., Ensergueix, D., Badell, E., Moniz-Peireira, J., Gicquel, B., Winter, N. (2002). Plasmidic versus Insertional Cloning of Heterologous Genes in Mycobacterium bovis BCG: Impact on In Vivo Antigen Persistence and Immune Responses. Infect. Immun. 70: 303-314 [Abstract] [Full Text]  
• Horwitz, M. A., Harth, G., Dillon, B. J., Masle, S. (2000). Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 10.1073/pnas.250480397v1 [Abstract] [Full Text]  
• Nascimento, I. P., Dias, W. O., Mazzantini, R. P., Miyaji, E. N., Gamberini, M., Quintilio, W., Gebara, V. C., Cardoso, D. F., Ho, P. L., Raw, I., Winter, N., Gicquel, B., Rappuoli, R., Leite, L. C. C. (2000). Recombinant Mycobacterium bovis BCG Expressing Pertussis Toxin Subunit S1 Induces Protection against an Intracerebral Challenge with Live Bordetella pertussis in Mice. Infect. Immun. 68: 4877-4883 [Abstract] [Full Text]  
• Ahlborg, N., Ling, I. T., Holder, A. A., Riley, E. M. (2000). Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119. Infect. Immun. 68: 2102-2109 [Abstract] [Full Text]  
• FUJIEDA, S., IHO, S., KIMURA, Y., SUNAGA, H., IGAWA, H., SUGIMOTO, C., YAMAMOTO, S., SAITO, H. (1999). DNA from Mycobacterium bovis Bacillus Calmette-Guerin (MY-1) Inhibits Immunoglobulin E Production by Human Lymphocytes. Am. J. Respir. Crit. Care Med. 160: 2056-2061 [Abstract] [Full Text]  
• Marchant, A., Goetghebuer, T., Ota, M. O., Wolfe, I., Ceesay, S. J., De Groote, D., Corrah, T., Bennett, S., Wheeler, J., Huygen, K., Aaby, P., McAdam, K. P. W. J., Newport, M. J. (1999). Newborns Develop a Th1-Type Immune Response to Mycobacterium bovis Bacillus Calmette-Guerin Vaccination. J. Immunol. 163: 2249-2255 [Abstract] [Full Text]  
• Horwitz, M. A., Harth, G., Dillon, B. J., Maslesa-Galic', S. (2000). Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. USA 97: 13853-13858 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS